title: Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985-2002.
abstract: OBJECTIVE
  To identify predictive factors for moderate/severe liver fibrosis and to analyse fibrosis progression in paired liver biopsies from HIV-positive patients with chronic hepatitis C virus (HCV) infection.
  
  
  METHODS
  HIV/HCV coinfected patients followed at the 2nd Department of Infectious Diseases of L. Sacco Hospital in Milan, Italy, with at least one liver biopsy specimen were retrospectively evaluated.
  
  
  RESULTS
  A total of 110 patients were enrolled in the study. In a univariate analysis, predictive factors of Ishak-Knodell stage > or =3 were a history of alcohol abuse [odds ratio (OR) 3.6, P=0.004], alanine aminotransferase level >100 IU/L at biopsy (OR 2.4, P=0.05), necro-inflammatory grade > or =9 (OR 37.14, P<0.0001) and CD4 count <350 cells/microL at nadir (OR 5.3, P=0.05). In a multivariate analysis, age >35 years (OR 3.19, P=0.04) and alcohol abuse (OR 4.36, P=0.002) remained independently associated with Ishak-Knodell stage. Paired liver biopsies were available in 36 patients; 18 showed an increase of at least one stage in the subsequent liver biopsy. Either in a univariate or in a multivariate analysis, a decrease of CD4 cell count of more than 10% between two biopsies (OR 6.85, P=0.002) was significantly associated with liver fibrosis progression.
  
  
  CONCLUSIONS
  Our findings highlight the relevance of encouraging a withdrawal of alcohol consumption in people with chronic HCV infection and of carrying out close follow-up of patients, especially if they are more than 35 years old. It is therefore mandatory to evaluate HIV/HCV coinfected patients for anti-HCV treatment and to increase CD4 cell count through antiretroviral therapy in order to reduce the risk of fibrosis progression and to slow the evolution of liver disease.
authors.affiliation: 2nd Department of Infectious Diseases, Sacco Hospital, Milan, Italy. inf2div@hsacco.it
authors.forename: M
authors.initials: M
authors.lastname: Schiavini
authors.forename: E
authors.initials: E
authors.lastname: Angeli
authors.forename: A
authors.initials: A
authors.lastname: Mainini
authors.forename: P
authors.initials: P
authors.lastname: Zerbi
authors.forename: P G
authors.initials: PG
authors.lastname: Duca
authors.forename: G
authors.initials: G
authors.lastname: Gubertini
authors.forename: L
authors.initials: L
authors.lastname: Vago
authors.forename: P
authors.initials: P
authors.lastname: Fociani
authors.forename: R
authors.initials: R
authors.lastname: Giorgi
authors.forename: A
authors.initials: A
authors.lastname: Cargnel
mesh_terms: D000328:Adult; D000367:Age Factors; D000428:Alcohol Drinking; D001706:Biopsy; D018791:CD4 Lymphocyte Count; D018450:Disease Progression; D005260:Female; D015658:HIV Infections / Q000150:complications*; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D007558:Italy; D008099:Liver / Q000473:pathology*; D008103:Liver Cirrhosis / Q000209:etiology / Q000473:pathology; D008297:Male; D012189:Retrospective Studies; D012307:Risk Factors